Alcoy Korott, a company focused on manufacturing dietary supplements and phytotherapy products, faced a 26 percent revenue drop last year, coming in at 13.8 million euros. The decline stemmed largely from heavy reliance on its main client, Mercadona. With orders from the Juan Roig chain diminishing, the company moved to diversify its customer base. A key step in this strategy was joining the Euro Vital Pharma group, a move that opens doors to new markets and is expected to improve results in the near term.
Looking back at the prior year, turnover stood at 18.7 million euros, making the 2021 figures a clear downturn. The year closed with a negative net result of 1.2 million euros, marking a substantial 133 percent decrease. Management attributes the disruptions to the loss of business with Mercadona, the companys main customer, and emphasizes ongoing efforts to reduce this dependence. A decisive development in this regard was the June 2021 merger with the German Euro Vital Pharma Holding, which created a Europe wide group specializing in the production and marketing of food supplements, dietetics items, and other parapharmacy products, particularly private label offerings.
The broader operation soon revealed a large holding with annual turnover surpassing 100 million euros, a workforce around 300 employees, and a distribution network reaching more than 10,000 supermarkets, pharmacies, parapharmacies, and specialized centers across Europe. Alcoys objective became to serve as the industrial and research and development arm of this holding, since Euro Vital’s own production capacity remained limited at that stage.
This integration also surfaced Korotts Buy PowerGym, a sports nutrition brand and more recently Viveplus, a Madrid group focused on distribution, marketing, and sale of dietary foods and nutritional supplements. The collaboration reshaped Korotts strategy and positioned the company within a broader pan European platform for dietary products and private label offerings. In the years that followed, early results from these initiatives began to show progress, while Mercadona remained a critical but increasingly less dominant customer. The company continued to pursue a strategy of expanding its client base and exploring new market channels to stabilize revenue and reduce single client risk.
Company sources note that while initial gains from these strategic moves appeared in 2021 and 2022, Mercadona’s influence persisted as a substantial portion of income. Nevertheless, leadership remains hopeful about 2023 and beyond, pointing to financial solvency and the ongoing onboarding of alternative customers as indicators of a rising sales trajectory. The expectation is for turnover to trend upward in the coming years as the organization leverages the strength of the new European group and diversifies its customer portfolio. While Mercadona’s share is projected to decline from its peak, it is anticipated to account for around 30 percent of total turnover by year end, reflecting a more balanced revenue mix and a more resilient business model marquee of the group’s broader strategy. [citation needed]